Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy

BACKGROUND: Systemic chemotherapies for various malignancies have been shown to significantly, yet transiently, decrease numbers of CD4(+) T lymphocytes, a major reservoir for human immunodeficiency virus type 1 (HIV-1) infection. However, little is known about the impact of cytoreductive chemothera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Henrich, Timothy J, Hobbs, Kristen S, Hanhauser, Emily, Scully, Eileen, Hogan, Louise E, Robles, Yvonne P, Leadabrand, Kaitlyn S, Marty, Francisco M, Palmer, Christine D, Jost, Stephanie, Körner, Christian, Li, Jonathan Z, Gandhi, Rajesh T, Hamdan, Ayad, Abramson, Jeremy, LaCasce, Ann S, Kuritzkes, Daniel R
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Major Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853412/
https://ncbi.nlm.nih.gov/pubmed/28838149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados